About Ethics Committee of Shanghai Renji Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ethics Committee of Shanghai Renji Hospital
During the past decade, Ethics Committee of Shanghai Renji Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ethics Committee of Shanghai Renji Hospital"
#1 collaborator was "First Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator, "Peking University First Hospital" with 2 trials as a collaborator, "Ruijin Hospital" with 2 trials as a collaborator, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials as a collaborator and "Shanghai 10th People's Hospital" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Ethics Committee of Shanghai Renji Hospital
According to Clinical.Site data, the most researched conditions in "Ethics Committee of Shanghai Renji Hospital" are
"Renal Cell Carcinoma" (2 trials), "ALK Gene Mutation" (1 trials), "BAP1 Tumor Predisposition Syndrome" (1 trials), "Biomarkers" (1 trials) and "Birt-Hogg-Dube Syndrome" (1 trials). Many other conditions were trialed in "Ethics Committee of Shanghai Renji Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Ethics Committee of Shanghai Renji Hospital
Most popular intervention types in "Ethics Committee of Shanghai Renji Hospital" are "Procedure" (3 trials), "Drug" (2 trials), "Radiation" (2 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Camrelizumab" (1 trials), "Distal gastrectomy" (1 trials), "Docetaxel" (1 trials), "FOLFOXIRI" (1 trials) and "FU-based chemoradiotherapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ethics Committee of Shanghai Renji Hospital
The vast majority of trials in "Ethics Committee of Shanghai Renji Hospital" are
9 trials for "All" genders.
Clinical Trials Status at Ethics Committee of Shanghai Renji Hospital
Currently, there are NaN active trials in "Ethics Committee of Shanghai Renji Hospital".
1 are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Ethics Committee of Shanghai Renji Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ethics Committee of Shanghai Renji Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Ethics Committee of Shanghai Renji Hospital
Ethics Committee of Shanghai Renji Hospital has several departments that took part in Clinical trials: "Phase-I Clinical Research Unit at Shanghai Xuhui Center hospital" - 2 trials